Rilzabrutinib (Wayrilz; Sanofi) may improve immune thrombocytopenia (ITP) outcomes, enable early intervention, and enhance patient quality of life. In an interview with The American Journal of Managed ...

While Sanofi originally had its eye on tolebrutinib when it purchased its partner Principia Biopharma for $3.7 billion five years ago, another one of the Bruton tyrosine kinase (BTK) inhibitors ...

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by autoantibody-mediated platelet destruction. Treatment with CM313, a novel anti-CD38 monoclonal antibody, can result in targeted ...

A diagnosis of immune thrombocytopenia (ITP), previously known as idiopathic thrombocytopenia, can bring up a lot of questions. Make sure you’re prepared at your next doctor’s appointment by having ...

MedPage Today has been reporting on a variety of subjects relating to immune thrombocytopenia, from identifying risk factors to improving patient outcomes. Answer these questions to see how much ...

"This paper provides important perspectives in that there’s a higher incidence of cancer diagnoses within the first year after ITP diagnosis and a slower but rising cumulative incidence thereafter. It ...

Idiopathic thrombocytopenic purpura (ITP), also known as primary immune thrombocytopenic purpura and autoimmune thrombocytopenic purpura, is defined as isolated thrombocytopenia with normal bone ...

What Is Doptelet, and Why Does It Matter? Doptelet (avatrombopag) is a prescription medicine that helps the body make more platelets (cells that help stop bleeding). First approved in 2018 for adults, ...

Chrystal Gellein was 18 years old and living in Courtenay, B.C., when she was diagnosed with a life-threatening bleeding disorder called Immune thrombocytopenic purpura (ITP). After 20 years of ...